{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T18:36:30Z","timestamp":1772908590042,"version":"3.50.1"},"reference-count":120,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","physicamedica.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physica Medica"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ejmp.2026.105752","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T20:19:46Z","timestamp":1770409186000},"page":"105752","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Recommendations for the dosimetry of patients undergoing therapy with radiopharmaceuticals that include 177Lu"],"prefix":"10.1016","volume":"143","author":[{"given":"Pablo M\u00ednguez","family":"Gabi\u00f1a","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuria Carrasco","family":"Vela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leticia Irazola","family":"Rosales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep Mar\u00eda","family":"Mart\u00ed-Climent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Carlos","family":"Mart\u00ednez G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa Monserrat","family":"Fuertes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Montes","family":"Fuentes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo Montes","family":"Uruen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel Barquero","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmp.2026.105752_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nds.2019.100514","article-title":"Nuclear data sheets for A=177","volume":"159","author":"Kondev","year":"2019","journal-title":"Nucl Data Sheets"},{"key":"10.1016\/j.ejmp.2026.105752_b0010","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.apradiso.2011.02.012","article-title":"Precision electron-gamma spectroscopic measurements in the decay of 177Lu","volume":"69","author":"Deepa","year":"2011","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.ejmp.2026.105752_b0015","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s12149-018-1230-7","article-title":"Manual on the proper use of lutetium-177-labeled somatostatin analogue (Lu-177-DOTA-TATE) injectable in radionuclide therapy","volume":"32","author":"Hosono","year":"2018","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.ejmp.2026.105752_b0020","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0969-8043(00)00362-6","article-title":"Standardisation and decay data of 177Lu and 188Re","volume":"55","author":"Sch\u00f6tzig","year":"2001","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.ejmp.2026.105752_b0025","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1007\/s00259-021-05392-2","article-title":"Challenges and future options for the production of lutetium-177","volume":"48","author":"Vogel","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ejmp.2026.105752_b0030","doi-asserted-by":"crossref","first-page":"976","DOI":"10.2967\/jnumed.115.155390","article-title":"Long-term retention of 177Lu\/177mLu-DOTATATE in patients investigated by \u03b3-spectrometry and \u03b3-camera imaging","volume":"56","author":"Gleisner","year":"2015","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejmp.2026.105752_b0035","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s002590100574","article-title":"[177Lu-DOTAOTyr3]octreotate: comparison with [111In-DTPAo]octreotide in patients","volume":"28","author":"Kwekkeboom","year":"2001","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.ejmp.2026.105752_b0040","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1200\/JCO.2005.08.066","article-title":"Radiolabeled somatostatin analog [177Lu-DOTA0,Tyr3]octreotate in patients with endocrine gastroenteropancreatic tumors","volume":"23","author":"Kwekkeboom","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejmp.2026.105752_b0045","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa1607427","article-title":"Phase 3 Trial of 177Lu-dotatate for midgut neuroendocrine tumors","volume":"376","author":"Strosberg","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejmp.2026.105752_b0050","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1007\/s00259-023-06166-8","article-title":"Efficacy of [177Lu]Lu\u2011DOTATATE in metastatic neuroendocrine neoplasms of different locations: data from the SEPTRALU study","volume":"50","author":"Mitjavila","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ejmp.2026.105752_b0055","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1007\/s00259-017-3678-4","article-title":"Individualised 177 Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry","volume":"44","author":"Sundl\u00f6v","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ejmp.2026.105752_b0060","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1007\/s00259-018-3945-z","article-title":"Prospective observational study of 177 Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity","volume":"45","author":"Garske-Rom\u00e1n","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ejmp.2026.105752_b0065","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1007\/s00259-018-4209-7","article-title":"Personalized 177Lu- octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: a simulation study","volume":"46","author":"Del Prete","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ejmp.2026.105752_b0070","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1007\/s00259-022-05786-w","article-title":"Phase II trial demonstrates the efficacy and safety of individualized, dosimetry-based 177Lu-DOTATATE treatment of NET patients","volume":"49","author":"Sundl\u00f6v","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ejmp.2026.105752_b0075","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13164023","article-title":"PSMA theranostics: current landscape and future outlook","volume":"13","author":"Zhang","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejmp.2026.105752_b0080","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22040523","article-title":"Metal-based PSMA radioligands","volume":"22","author":"Gourni","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.ejmp.2026.105752_b0085","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12061367","article-title":"PSMA theranostics: review of the current status of PSMA-targeted imaging and radioligand therapy","volume":"12","author":"Jones","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejmp.2026.105752_b0090","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/MNM.0000000000000606","article-title":"Post-therapeutic dosimetry of 177Lu-DKFZ-PSMA-617 in the treatment of patients with metastatic castration-resistant prostate cancer","volume":"38","author":"Yadav","year":"2017","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.ejmp.2026.105752_b0095","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00259-016-3481-7","article-title":"Lu-DKFZ-PSMA-617 therapy in metastatic castration resistant prostate cancer: safety, efficacy, and quality of life assessment","volume":"44","author":"Yadav","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ejmp.2026.105752_b0100","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00259-015-3174-7","article-title":"Dosimetry for (177)Lu-DKFZ-PSMA-617: a new radiopharmaceutical for the treatment of metastatic prostate cancer","volume":"43","author":"Delker","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ejmp.2026.105752_b0105","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJMoa2107322","article-title":"Lutetium-177-PSMA-617 for metastatic castration-resistant prostate cancer","volume":"385","author":"Sartor","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejmp.2026.105752_b0110","unstructured":"Real Decreto 601\/2019, de 18 de octubre, sobre justificaci\u00f3n y optimizaci\u00f3n del uso de las radiaciones ionizantes para la protecci\u00f3n radiol\u00f3gica de las personas con ocasi\u00f3n de exposiciones m\u00e9dicas."},{"key":"10.1016\/j.ejmp.2026.105752_b0115","unstructured":"Council Directive 2013\/59\/EURATOM of 5 December 2013 laying down basic safety standards for protection against the dangers arising from exposure to ionising radiation, and repealing Directives 89\/618\/Euratom, 90\/641\/Euratom, 96\/29\/Euratom, 97\/43\/Euratom and 2003\/122\/Euratom. Official Journal of the European Union; 2014. p. 1-73."},{"key":"10.1016\/j.ejmp.2026.105752_b0120","unstructured":"Real Decreto 673\/2023, de 18 de julio, por el que se establecen los criterios de calidad y seguridad de las unidades asistenciales de medicina nuclear."},{"key":"10.1016\/j.ejmp.2026.105752_b0125","unstructured":"Loevinger R, Budinger T, Watson E, Society of Nuclear Medicine . Medical Internal Radiation Dose C. MIRD primer for absorbed dose calculations. Rev. ed. New York, NY: Society of Nuclear Medicine; 1991."},{"key":"10.1016\/j.ejmp.2026.105752_b0130","unstructured":"ICRU Report 96, Dosimetry-Guided Radiopharmaceutical Therapy. Bethesda: International Commission on Radiation Units and Measurements; 2022."},{"key":"10.1016\/j.ejmp.2026.105752_b0135","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejmp.2021.11.001","article-title":"Overview of commercial treatment planning systems for targeted radionuclide therapy","volume":"92","author":"Della Gala","year":"2021","journal-title":"Phys Med"},{"key":"10.1016\/j.ejmp.2026.105752_b0140","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.1002\/mp.14375","article-title":"Comparison of commercial dosimetric software platforms in patients treated with 177Lu-DOTATATE for peptide receptor radionuclide therapy","volume":"47","author":"Mora-Ramirez","year":"2020","journal-title":"Med Phys"},{"key":"10.1016\/j.ejmp.2026.105752_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmp.2025.104965","article-title":"Methodology for comparing absorbed dose rate calculation algorithms in molecular radiotherapy dosimetry","volume":"133","author":"Fragoso-Negr\u00edn","year":"2025","journal-title":"Phys Med"},{"key":"10.1016\/j.ejmp.2026.105752_b0150","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1007\/s00259-018-4136-7","article-title":"EANM practical guidance on uncertainty analysis for molecular radiotherapy absorbed dose calculations","volume":"45","author":"Gear","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ejmp.2026.105752_b0155","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1088\/0031-9155\/13\/2\/306","article-title":"A formalism for calculation of absorbed dose from radionuclides","volume":"13","author":"Loevinger","year":"1968","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ejmp.2026.105752_b0160","doi-asserted-by":"crossref","unstructured":"Bolch WE, Eckerman KF, Sgouros G, Thomas SR. MIRD pamphlet No. 21: a generalized schema for radiopharmaceutical dosimetry--standardization of nomenclature. J Nucl Med. 2009;50:477-84. doi:10.2967\/jnumed.108.056036.","DOI":"10.2967\/jnumed.108.056036"},{"key":"10.1016\/j.ejmp.2026.105752_b0165","first-page":"1023","article-title":"OLINDA\/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine","volume":"46","author":"Stabin","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejmp.2026.105752_b0170","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13550-017-0339-3","article-title":"IDAC-Dose 2.1, an internal dosimetry program for diagnostic nuclear medicine based on the ICRP adult reference voxel phantoms","volume":"7","author":"Andersson","year":"2017","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.ejmp.2026.105752_b0175","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.2967\/jnumed.119.240366","article-title":"OpenDose: open-access resource for nuclear medicine dosimetry","volume":"61","author":"Chauvin","year":"2020","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejmp.2026.105752_b0180","first-page":"1","article-title":"133: the ICRP computational framework for internal dose assessment for reference adults: specific absorbed fractions","author":"Publication","year":"2016","journal-title":"Ann ICRP"},{"key":"10.1016\/j.ejmp.2026.105752_b0185","doi-asserted-by":"crossref","DOI":"10.1007\/s00259-022-05727-7","article-title":"EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands","author":"Sj\u00f6green Gleisner","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ejmp.2026.105752_b0190","unstructured":"Snyder W, Ford M, Warner G, Watson S. MIRD pamphlet no. 11:S, absorbed dose per unit cumulated activity for selected radionuclides and organs. New York, NY: Society of Nuclear Medicine; 1975."},{"key":"10.1016\/j.ejmp.2026.105752_b0195","doi-asserted-by":"crossref","first-page":"N479","DOI":"10.1088\/0031-9155\/54\/20\/N02","article-title":"Absorbed fractions for photons in ellipsoidal volumes","volume":"54","author":"Amato","year":"2009","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ejmp.2026.105752_b0200","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1088\/0031-9155\/54\/13\/013","article-title":"Absorbed fractions in ellipsoidal volumes for beta(-) radionuclides employed in internal radiotherapy","volume":"54","author":"Amato","year":"2009","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ejmp.2026.105752_b0205","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1088\/0031-9155\/57\/2\/517","article-title":"A free database of radionuclide voxel S values for the dosimetry of nonuniform activity distributions","volume":"57","author":"Lanconelli","year":"2012","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ejmp.2026.105752_b0210","first-page":"11S","article-title":"MIRD pamphlet No. 17: the dosimetry of nonuniform activity distributions\u2013radionuclide S values at the voxel level. Medical Internal Radiation Dose Committee","volume":"40","author":"Bolch","year":"1999","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejmp.2026.105752_b0215","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3109\/0284186X.2011.584559","article-title":"The accuracy of absorbed dose estimates in tumours determined by quantitative SPECT: a Monte Carlo study","volume":"50","author":"Ljungberg","year":"2011","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ejmp.2026.105752_b0220","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40658-018-0213-z","article-title":"Inter-comparison of quantitative imaging of lutetium-177 (177Lu) in European hospitals","volume":"5","author":"Wevrett","year":"2018","journal-title":"EJNMMI Phys"},{"key":"10.1016\/j.ejmp.2026.105752_b0225","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s40658-021-00397-0","article-title":"A multicentre and multi-national evaluation of the accuracy of quantitative Lu-177 SPECT\/CT imaging performed within the MRTDosimetry project","volume":"8","author":"Tran-Gia","year":"2021","journal-title":"EJNMMI Phys"},{"key":"10.1016\/j.ejmp.2026.105752_b0230","unstructured":"Montes C, Alvarez D, Gonzalez C, Marti JM, Terron JA, Vicedo A. Protocolo de control de calidad de la instrumentaci\u00f3n de Medicina Nuclear versi\u00f3n 2020. In: SEFM-SEMNIM-SEPR, editor. Madrid: CREIN, Soluciones Integrales de Comunicaci\u00f3n; 2020."},{"key":"10.1016\/j.ejmp.2026.105752_b0235","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s40658-020-00338-3","article-title":"An international multi-center investigation on the accuracy of radionuclide calibrators in nuclear medicine theragnostics","volume":"7","author":"Saldarriaga Vargas","year":"2020","journal-title":"EJNMMI Phys"},{"key":"10.1016\/j.ejmp.2026.105752_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmp.2023.103170","article-title":"Traceable calibration with 177Lu and comparison of activity meters at hospitals in Norway and Sweden","volume":"116","author":"Hindorf","year":"2023","journal-title":"Phys Med"},{"key":"10.1016\/j.ejmp.2026.105752_b0245","unstructured":"Dominguez P, Escalada C, Ferrer N, Garcia-Tora\u00f1o E, Plaza R, Rodriguez C, et al. Protocolo para la calibracion y el uso de activimetros. CIEMAT-SEFM-SEMN-SEPR-SERFA; 2003."},{"key":"10.1016\/j.ejmp.2026.105752_b0250","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat Methods"},{"key":"10.1016\/j.ejmp.2026.105752_b0255","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.mri.2012.05.001","article-title":"3D Slicer as an image computing platform for the Quantitative Imaging Network","volume":"30","author":"Fedorov","year":"2012","journal-title":"Magn Reson Imaging"},{"key":"10.1016\/j.ejmp.2026.105752_b0260","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.2967\/jnumed.111.100123","article-title":"MIRD pamphlet No. 23: quantitative SPECT for patient-specific 3-dimensional dosimetry in internal radionuclide therapy","volume":"53","author":"Dewaraja","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejmp.2026.105752_b0265","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2967\/jnumed.115.159012","article-title":"26: Joint EANM\/MIRD guidelines for Quantitative 177Lu SPECT applied for dosimetry of radiopharmaceutical therapy","volume":"57","author":"Ljungberg","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejmp.2026.105752_b0270","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1109\/42.97591","article-title":"A practical method for position-dependent Compton-scatter correction in single photon emission CT","volume":"10","author":"Ogawa","year":"1991","journal-title":"IEEE Trans Med Imaging"},{"key":"10.1016\/j.ejmp.2026.105752_b0275","doi-asserted-by":"crossref","first-page":"616","DOI":"10.2967\/jnumed.117.200170","article-title":"Optimizing image quantification for 177 Lu SPECT\/CT based on a 3D printed 2-compartment kidney phantom","volume":"59","author":"Tran-Gia","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejmp.2026.105752_b0280","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40658-020-0282-7","article-title":"EANM Dosimetry Committee series on standard operational procedures for internal dosimetry for 131I mIBG treatment of neuroendocrine tumours","volume":"7","author":"Gear","year":"2020","journal-title":"EJNMMI Phys"},{"key":"10.1016\/j.ejmp.2026.105752_b0285","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40658-017-0174-7","article-title":"Accuracy and precision assessment for activity quantification in individualized dosimetry of 177Lu-DOTATATE therapy","volume":"4","author":"Marin","year":"2017","journal-title":"EJNMMI Phys"},{"key":"10.1016\/j.ejmp.2026.105752_b0290","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejmp.2018.12.029","article-title":"Partial volume effect of SPECT images in PRRT with 177Lu labelled somatostatin analogues: a practical solution","volume":"57","author":"Finocchiaro","year":"2019","journal-title":"Phys Med"},{"key":"10.1016\/j.ejmp.2026.105752_b0295","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40658-021-00365-8","article-title":"The effect of calibration factors and recovery coefficients on 177Lu SPECT activity quantification accuracy: a Monte Carlo study","volume":"8","author":"Ramonaheng","year":"2021","journal-title":"EJNMMI Phys"},{"key":"10.1016\/j.ejmp.2026.105752_b0300","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2967\/jnumed.114.148437","article-title":"Dose response of pancreatic neuroendocrine tumors treated with peptide receptor radionuclide therapy using 177Lu-DOTATATE","volume":"56","author":"Ilan","year":"2015","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejmp.2026.105752_b0305","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40658-018-0210-2","article-title":"Feasibility of simplifying renal dosimetry in 177Lu peptide receptor radionuclide therapy","volume":"5","author":"Sundl\u00f6v","year":"2018","journal-title":"EJNMMI Phys"},{"key":"10.1016\/j.ejmp.2026.105752_b0310","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40658-016-0148-1","article-title":"Organ-specific SPECT activity calibration using 3D printed phantoms for molecular radiotherapy dosimetry","volume":"3","author":"Robinson","year":"2016","journal-title":"EJNMMI Phys"},{"key":"10.1016\/j.ejmp.2026.105752_b0315","first-page":"68","article-title":"Activity recovery for differently shaped objects in quantitative SPECT","author":"M\u00ednguez Gabi\u00f1a","year":"2023","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ejmp.2026.105752_b0320","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2967\/jnumed.124.268520","article-title":"32: a MIRD recovery coefficient model for resolution characterization and shape-specific partial-volume correction","volume":"66","author":"Marquis","year":"2025","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejmp.2026.105752_b0325","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40658-017-0202-7","article-title":"Deadtime effects in quantification of 177Lu activity for radionuclide therapy","volume":"5","author":"Uribe","year":"2018","journal-title":"EJNMMI Phys"},{"key":"10.1016\/j.ejmp.2026.105752_b0330","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1118\/1.598162","article-title":"Deadtime correction for two multihead Anger cameras in 131I dual-energy-window-acquisition mode","volume":"25","author":"Koral","year":"1998","journal-title":"Med Phys"},{"key":"10.1016\/j.ejmp.2026.105752_b0335","doi-asserted-by":"crossref","DOI":"10.1118\/1.4792297","article-title":"Characterization of the count rate performance of modern gamma cameras","volume":"40","author":"Silosky","year":"2013","journal-title":"Med Phys"},{"key":"10.1016\/j.ejmp.2026.105752_b0340","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s40658-022-00484-w","article-title":"Impact of the dead-time correction method on quantitative 177Lu-SPECT (QSPECT) and dosimetry during radiopharmaceutical therapy","volume":"9","author":"Desy","year":"2022","journal-title":"EJNMMI Phys"},{"key":"10.1016\/j.ejmp.2026.105752_b0345","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1007\/s00259-010-1422-4","article-title":"EANM Dosimetry Committee guidelines for bone marrow and whole-body dosimetry","volume":"37","author":"Hindorf","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ejmp.2026.105752_b0350","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2967\/jnumed.112.107524","article-title":"Individualized dosimetry of kidney and bone marrow in patients undergoing 177Lu-DOTA-octreotate treatment","volume":"54","author":"Sandstr\u00f6m","year":"2013","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejmp.2026.105752_b0355","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/2191-219X-2-49","article-title":"Estimation of absorbed dose to the kidneys in patients after treatment with 177Lu-octreotate: comparison between methods based on planar scintigraphy","volume":"2","author":"Larsson","year":"2012","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.ejmp.2026.105752_b0360","doi-asserted-by":"crossref","DOI":"10.2967\/jnumed.123.265484","article-title":"Specific uptake in the bone marrow causes high absorbed red marrow doses during [177Lu]Lu-DOTATATE treatment","author":"Hemmingsson","year":"2023","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejmp.2026.105752_b0365","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.2967\/jnumed.118.225235","article-title":"Bone marrow absorbed doses and correlations with hematologic response during 177Lu-DOTATATE treatments are influenced by image-based dosimetry method and presence of skeletal metastases","volume":"60","author":"Hagmarker","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejmp.2026.105752_b0370","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13550-018-0427-z","article-title":"Patient-specific image-based bone marrow dosimetry in Lu-177-[DOTA0,Tyr3]-Octreotate and Lu-177-DKFZ-PSMA-617 therapy: investigation of a new hybrid image approach","volume":"8","author":"Gosewisch","year":"2018","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.ejmp.2026.105752_b0375","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40658-024-00615-5","article-title":"Impact of different models based on blood samples and images for bone marrow dosimetry after 177Lu\u2011labeled somatostatin\u2011receptor therapy","volume":"11","author":"Vallot","year":"2024","journal-title":"EJNMMI Phys"},{"key":"10.1016\/j.ejmp.2026.105752_b0380","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40658-024-00636-0","article-title":"Bone marrow dosimetry in low volume mHSPC patients receiving Lu-177-PSMA therapy using SPECT\/CT","volume":"11","author":"Grob","year":"2024","journal-title":"EJNMMI Phys"},{"key":"10.1016\/j.ejmp.2026.105752_b0385","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2967\/jnumed.123.266843","article-title":"SPECT\/CT image-derived absorbed dose to red marrow correlates with hematologic toxicity in patients treated with [177Lu]Lu-DOTATATE","volume":"65","author":"Blakkisrud","year":"2024","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejmp.2026.105752_b0390","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s11307-014-0806-4","article-title":"Quantitative SPECT\/CT imaging of (177)Lu with In vivo validation in patients undergoing peptide receptor radionuclide therapy","volume":"17","author":"Sanders","year":"2015","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.ejmp.2026.105752_b0395","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/cncr.24796","article-title":"177Lu-[DOTA0,Tyr3] octreotate therapy in patients with disseminated neuroendocrine tumors: analysis of dosimetry with impact on future therapeutic strategy","volume":"116","author":"Garkavij","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.ejmp.2026.105752_b0400","first-page":"335","article-title":"Segmentation of whole-body images into two compartments in model for bone marrow dosimetry increases the correlation with hematological response in","volume":"32","author":"Hagmarker","year":"2017","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.ejmp.2026.105752_b0405","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40658-016-0157-0","article-title":"A novel planar image-based method for bone marrow dosimetry in (177)Lu-DOTATATE treatment correlates with haematological toxicity","volume":"3","author":"Svensson","year":"2016","journal-title":"EJNMMI Phys"},{"key":"10.1016\/j.ejmp.2026.105752_b0410","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1007\/s00259-015-3125-3","article-title":"Pre-therapeutic dosimetry of normal organs and tissues of (177)Lu-PSMA-617 prostate-specific membrane antigen (PSMA) inhibitor in patients with castration-resistant prostate cancer","volume":"42","author":"Kabasakal","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ejmp.2026.105752_b0415","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.2967\/jnumed.115.171397","article-title":"PSMA-targeted radionuclide therapy of metastatic castration-resistant prostate cancer with 177Lu-Labeled PSMA-617","volume":"57","author":"Kratochwil","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejmp.2026.105752_b0420","doi-asserted-by":"crossref","first-page":"528","DOI":"10.2967\/jnumed.120.245548","article-title":"Deep-learning generation of synthetic intermediate projections improves 177Lu SPECT images reconstructed with sparsely acquired projections","volume":"62","author":"Ryd\u00e9n","year":"2021","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejmp.2026.105752_b0425","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1097\/MNM.0b013e3283598395","article-title":"The accuracy and reproducibility of SPECT target volumes and activities estimated using an iterative adaptive thresholding technique","volume":"33","author":"Grimes","year":"2012","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.ejmp.2026.105752_b0430","article-title":"A threshold selection method from gray-level histograms","volume":"SMC-9(1):62\u20136","author":"Otsu","year":"1979","journal-title":"IEEE Trans Syst Man Cybern"},{"key":"10.1016\/j.ejmp.2026.105752_b0435","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13550-017-0262-7","article-title":"SPECT image segmentation for estimation of tumour volume and activity concentration in 177Lu-DOTATATE radionuclide therapy","volume":"7","author":"Gustafsson","year":"2017","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.ejmp.2026.105752_b0440","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3389\/fonc.2018.00215","article-title":"Deep learning renal segmentation for fully automated radiation dose estimation in unsealed source therapy","volume":"8","author":"Jackson","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejmp.2026.105752_b0445","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s00259-009-1216-8","article-title":"Individualized dosimetry in patients undergoing therapy with (177)Lu-DOTA-D-Phe (1)-Tyr (3)-octreotate","volume":"37","author":"Sandstr\u00f6m","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ejmp.2026.105752_b0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmp.2024.103335","article-title":"Kidney dosimetry in [177Lu]Lu-DOTA-TATE therapy based on multiple small VOIs","volume":"120","author":"Curkic Kapidzic","year":"2024","journal-title":"Phys Med"},{"key":"10.1016\/j.ejmp.2026.105752_b0455","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1159\/000507761","article-title":"Pituitary function after high-dose 177Lu-DOTATATE therapy and long-term follow-up","volume":"111","author":"Sundl\u00f6v","year":"2021","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.ejmp.2026.105752_b0460","first-page":"37S","article-title":"MIRD pamphlet no. 16: Techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates","volume":"40","author":"Siegel","year":"1999","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejmp.2026.105752_b0465","doi-asserted-by":"crossref","unstructured":"Huizing DMV, de Wit-van der Veen BJ, Verheij M, Stokkel MPM. Dosimetry methods and clinical applications in peptide receptor radionuclide therapy for neuroendocrine tumours: a literature review. EJNMMI Res. 2018;8:89. doi:10.1186\/s13550-018-0443-z.","DOI":"10.1186\/s13550-018-0443-z"},{"key":"10.1016\/j.ejmp.2026.105752_b0470","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.2967\/jnumed.107.047159","article-title":"Optimized 124I PET dosimetry protocol for radioiodine therapy of differentiated thyroid cancer","volume":"49","author":"Jentzen","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejmp.2026.105752_b0475","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2967\/jnumed.117.193706","article-title":"Dose mapping after endoradiotherapy with 177Lu-DOTATATE\/DOTATOC by a Single measurement after 4 days","volume":"59","author":"H\u00e4nscheid","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejmp.2026.105752_b0480","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40658-018-0232-9","article-title":"Feasibility and accuracy of single time point imaging for renal dosimetry following 177Lu-DOTATATE (\u2018Lutate\u2019) therapy","volume":"5","author":"Willowson","year":"2018","journal-title":"EJNMMI Phys"},{"key":"10.1016\/j.ejmp.2026.105752_b0485","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.2967\/jnumed.120.254656","article-title":"Feasibility of single-time-point dosimetry for radiopharmaceutical therapies","volume":"62","author":"Hou","year":"2021","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejmp.2026.105752_b0490","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejmp.2022.06.002","article-title":"Is a single late SPECT\/CT based kidney 177Lu-dosimetry superior to hybrid dosimetry with sequential multiple time-point whole-body planar scans in combination with an early SPECT\/CT?","volume":"100","author":"Beykan","year":"2022","journal-title":"Phys Med"},{"key":"10.1016\/j.ejmp.2026.105752_b0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmp.2024.104865","article-title":"Few-time-points time-integrated activity coefficients calculation using non-linear mixed-effects modeling: proof of concept for [111In]In-DOTA-TATE in kidneys","volume":"129","author":"Subangun","year":"2025","journal-title":"Phys Med"},{"key":"10.1016\/j.ejmp.2026.105752_b0500","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.2967\/jnumed.119.233411","article-title":"Radiation Dosimetry in (177)Lu-PSMA-617 therapy using a single posttreatment SPECT\/CT scan: a novel methodology to generate time- and tissue-specific dose factors","volume":"61","author":"Jackson","year":"2020","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejmp.2026.105752_b0505","first-page":"67","article-title":"Theoretical aspects on the use of single-time-point dosimetry for radionuclide therapy","author":"Gustafsson","year":"2022","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ejmp.2026.105752_b0510","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2967\/jnumed.121.262069","article-title":"Dosimetric quantities of neuroendocrine tumors over treatment cycles with 177Lu-DOTA-TATE","volume":"63","author":"Roth","year":"2022","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejmp.2026.105752_b0515","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3109\/0284186X.2011.618511","article-title":"Minor changes in effective half-life during fractionated 177Lu-octreotate therapy","volume":"51","author":"Garske","year":"2012","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ejmp.2026.105752_b0520","article-title":"107: nuclear decay data for dosimetric calculations","author":"Publication","year":"2008","journal-title":"Ann ICRP"},{"key":"10.1016\/j.ejmp.2026.105752_b0525","first-page":"1","article-title":"89: basic anatomical and physiological data for use in radiological protection reference values","author":"Publication","year":"2002","journal-title":"Ann ICRP"},{"key":"10.1016\/j.ejmp.2026.105752_b0530","article-title":"110: adult reference computational phantoms","author":"Publication","year":"2009","journal-title":"Ann ICRP"},{"key":"10.1016\/j.ejmp.2026.105752_b0535","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s11307-016-0942-0","article-title":"Lacrimal glands may represent organs at risk for radionuclide therapy of prostate cancer with [(177)Lu]DKFZ-PSMA-617","volume":"18","author":"Hohberg","year":"2016","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.ejmp.2026.105752_b0540","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/IOP.0000000000000117","article-title":"Age, gender, and interracial variability of normal lacrimal gland volume using MRI","volume":"30","author":"Bukhari","year":"2014","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"10.1016\/j.ejmp.2026.105752_b0545","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2967\/jnumed.112.105825","article-title":"Study of the impact of tissue density heterogeneities on 3-dimensional abdominal dosimetry: comparison between dose kernel convolution and direct Monte Carlo methods","volume":"54","author":"Dieudonn\u00e9","year":"2013","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejmp.2026.105752_b0550","first-page":"492","article-title":"Contribution to red marrow absorbed dose from total body activity: a correction to the MIRD method","volume":"42","author":"Stabin","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejmp.2026.105752_b0555","doi-asserted-by":"crossref","first-page":"5231","DOI":"10.1088\/0031-9155\/52\/17\/009","article-title":"Influence of total-body mass on the scaling of S-factors for patient-specific, blood-based red-marrow dosimetry","volume":"52","author":"Traino","year":"2007","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ejmp.2026.105752_b0560","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13550-018-0386-4","article-title":"External radiation exposure, excretion, and effective half-life in 177 Lu-PSMA-targeted therapies","volume":"8","author":"Kurth","year":"2018","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.ejmp.2026.105752_b0565","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1007\/s00259-015-3083-9","article-title":"DNA damage in blood lymphocytes in patients after (177)Lu peptide receptor radionuclide therapy","volume":"42","author":"Eberlein","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ejmp.2026.105752_b0570","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4274\/mirt.08760","article-title":"Lu-177-PSMA-617 prostate-specific membrane antigen inhibitor therapy in patients with castration-resistant prostate cancer: stability, bio-distribution and dosimetry","volume":"26","author":"Kabasakal","year":"2017","journal-title":"Mol Imaging Radionucl Ther"},{"key":"10.1016\/j.ejmp.2026.105752_b0575","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejmp.2018.11.001","article-title":"A dosimetry procedure for organs-at-risk in 177Lu peptide receptor radionuclide therapy of patients with neuroendocrine tumours","volume":"56","author":"Marin","year":"2018","journal-title":"Phys Med"},{"key":"10.1016\/j.ejmp.2026.105752_b0580","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1007\/s00259-016-3382-9","article-title":"Nephrotoxicity after PRRT with (177)Lu-DOTA-octreotate","volume":"43","author":"Bergsma","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ejmp.2026.105752_b0585","doi-asserted-by":"crossref","DOI":"10.1097\/MNM.0000000000001658","article-title":"Kidney absorbed radiation doses for [177Lu]Lu-PSMA-617 and [177Lu]Lu-PSMA-I&T determined by 3D clinical dosimetry","author":"Uijen","year":"2023","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.ejmp.2026.105752_b0590","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/s00259-021-05471-4","article-title":"Intra-therapeutic dosimetry of [177 Lu]Lu-PSMA-617 in low-volume hormone-sensitive metastatic prostate cancer patients and correlation with treatment outcome","volume":"49","author":"Peters","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ejmp.2026.105752_b0595","first-page":"406","article-title":"Results of individual patient dosimetry in peptide receptor radionuclide therapy with 177Lu DOTA-TATE and 177Lu DOTA-NOC","volume":"22","author":"Wehrmann","year":"2007","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.ejmp.2026.105752_b0600","doi-asserted-by":"crossref","first-page":"5004","DOI":"10.1002\/mp.13178","article-title":"A method for tumor dosimetry based on hybrid planar-SPECT\/CT images and semiautomatic segmentation","volume":"45","author":"Roth","year":"2018","journal-title":"Med Phys"}],"container-title":["Physica Medica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1120179726000396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1120179726000396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T02:21:52Z","timestamp":1772850112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1120179726000396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":120,"alternative-id":["S1120179726000396"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmp.2026.105752","relation":{},"ISSN":["1120-1797"],"issn-type":[{"value":"1120-1797","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recommendations for the dosimetry of patients undergoing therapy with radiopharmaceuticals that include 177Lu","name":"articletitle","label":"Article Title"},{"value":"Physica Medica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmp.2026.105752","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Associazione Italiana di Fisica Medica e Sanitaria. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105752"}}